Chemomab Therapeutics (CMMB) Current Assets (2011 - 2026)
Chemomab Therapeutics (CMMB) posted Current Assets of $9.96 million for Q2 2026, down 6.2% from $10.61 million a year earlier and down 13.2% from the prior quarter.
Powered by 
Analysis
Chemomab Therapeutics (CMMB) Current Assets (2011 - 2026) Analysis & Trends
At the end of FY2025, Chemomab Therapeutics' Current Assets came in at $13.43 million, down 16.3% from FY2024.
- Annual Current Assets has declined for four consecutive years, though with a five-year compound annual growth rate of 2.5% (FY2020 to FY2025).
- In prior years, Chemomab Therapeutics' Current Assets was $16.04 million in FY2024 (-23.2%), $20.9 million in FY2023 (-49.9%), $41.74 million in FY2022 (-33.4%) and $62.69 million in FY2021 (+429.5%).
- The Q2 2026 figure stands as the lowest quarterly Current Assets since Q3 2020.
- On a year-over-year basis, Current Assets has declined in each of the last 18 quarters, with an average decline of 18.9% over the last eight quarters.
- The strongest year-over-year quarter for Current Assets in the past five years was Q3 2021, with growth of 791.2%; the weakest was Q3 2023, with a decline of 54.1%.
- According to Business Quant data, Current Assets for the three prior quarters was $11.47 million (Q1 2026), $13.43 million (Q4 2025) and $11.93 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 64.67 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 59.77 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 33.67 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 36.68 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 27.35 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 27.97 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 34.96 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 13.95 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 41.36 Bn |
| 10 | Chemomab Therapeutics | 7.49 Mn | -27.66 Mn | - | 9.96 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 9.96 Mn |
| Mar 31, 2026 | 11.47 Mn |
| Dec 31, 2025 | 13.43 Mn |
| Sep 30, 2025 | 11.93 Mn |
| Jun 30, 2025 | 10.61 Mn |
| Mar 31, 2025 | 11.98 Mn |
| Dec 31, 2024 | 16.04 Mn |
| Sep 30, 2024 | 19.89 Mn |
| Jun 30, 2024 | 13.46 Mn |
| Mar 31, 2024 | 16.84 Mn |
| Dec 31, 2023 | 20.90 Mn |
| Sep 30, 2023 | 22.37 Mn |
| Jun 30, 2023 | 27.71 Mn |
| Mar 31, 2023 | 33.78 Mn |
| Dec 31, 2022 | 41.74 Mn |
| Sep 30, 2022 | 48.73 Mn |
| Jun 30, 2022 | 54.83 Mn |
| Mar 31, 2022 | 59.34 Mn |
| Dec 31, 2021 | 62.69 Mn |
| Sep 30, 2021 | 65.84 Mn |
API Access
Chemomab Therapeutics Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-assets&ticker=CMMB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-assets", "ticker": "CMMB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-assets&ticker=CMMB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();